Slide

NEWS & PRESS


All News & Press

February 27, 2023

CordenPharma CEO on Record CDMO Growth in 2022 & Expansion for 2023

Edition 1 / February 2023
Editorial > 2022-2023: A Continuation of Record Growth & Expansion
February 27, 2023

CordenPharma Sets Science-Based Emission Reduction Targets for Sustainability

Edition 1 / February 2023
Article > Sustainability Through Science-Based Targets
February 27, 2023

CordenPharma Expands Into GMP Lipid NanoParticle Formulation in Caponago

Edition 1 / February 2023
Article > CordenPharma Expands Into GMP Lipid NanoParticle Formulation
January 9, 2023

CordenPharma Signs Multi-Year Agreement for the Manufacturing of a Commercial Peptide

10 January, 2023
Press Release > CordenPharma Signs Multi-Year Agreement for the Manufacturing of a Large-Volume Commercial Peptide
December 1, 2022

CordenPharma Joins the Science Based Targets initiative (SBTi)

December 2, 2022
Press Release > CordenPharma joins the Science Based Targets initiative (SBTi) to set greenhouse gas emission reduction targets.
November 17, 2022

CPHI Online Interviews CEO on what CordenPharma Brings to the Future of Pharma

Nov 15, 2022
CPHI Online Interviews Dr. Michael Quirmbach at CPHI Frankfurt 2022.
October 20, 2022

Highly Potent CDMO Manufacturing Trends & Expansion

October 20, 2022
Chemistry Today interviews Dr. Brittany Hayes on Highly Potent CDMO manufacturing trends.
October 3, 2022

Corden Connect Editorial: Strategic Growth & Environmental Governance

Edition 3 / October 2022
Editorial > A New Chapter of Strategic Growth & Environmental Governance
October 3, 2022

Video Interview: CordenPharma’s New Private Equity Owners, Astorg

Edition 3 / October 2022
Video Interview > CordenPharma's New Private Equity Shareholders Astorg
October 3, 2022

Solid State Centre of Excellence Identifies Optimal Process Conditions for API Production

Edition 3 / October 2022
Article > CordenPharma’s New Centre of Excellence for Solid State
October 3, 2022

Increase Your Supply Chain Efficiency with Flow Chemistry Services

Edition 3 / October 2022
Animated Video > The Benefits of CordenPharma’s Flow Chemistry & Continuous Manufacturing Services
September 13, 2022

CDMO CEO Strategy to Grow Stronger Through Flexibility, Creativity & Resilience

Sept 13, 2022
PHARMAnetwork Interviews Dr. Michael Quirmbach in 2022 CDMO CEO Visions & Strategies Issue.
August 11, 2022

Mini-Tablet Dose Form Considerations for Pediatric Patients

August 11, 2022
PMPS Article > Dr. Brittany Hayes discusses mini-tablet dose form development considerations for pediatric patients.
July 15, 2022

Risk-based Process Design & Control Technologies Key to Cost-efficient Sterile Injectable Manufacturing

July 4, 2022
Manufacturing Chemist Article: Fabio Stevanon gives keys to cost-efficient sterile injectable manufacturing.
July 6, 2022

C&EN: Eiger and CordenPharma Bring Orphan Drug for Progeria to Market

July 1, 2022
C&EN Article: Eiger & CordenPharma Bring Orphan Drug Zokinvy (Lonafarnib) for Rare Disease Progeria to Market